Drug resistant TB: UK multicentre study (DRUMS): Treatment, management and outcomes in London and West Midlands 2008–2014 - 18/04/17
, Graham S. Cooke c, Onn Min Kon e, Martin Dedicoat d, Marc Lipman f, Angela Loyse a, Philip D. Butcher a, Irina Chis Ster a, Thomas Stephen Harrison aSummary |
Objectives |
Detailed information regarding treatment practices and outcomes of MDR-TB treatment in the UK is required as a baseline for care improvements.
Methods |
100 consecutive cases between 2008 and 2014 were reviewed retrospectively at 4 MDR-TB treatment centres in England to obtain information on drug treatment choices, hospital admission duration and outcomes for MDR-TB.
Results |
Initial hospital admission was long, median 62.5 (IQR 20–106, n = 92) days, and 13% (12/92) of patients lost their home during this period. Prolonged admission was associated with pulmonary cases, cavities on chest radiograph, a public health policy of waiting for sputum culture conversion (CC) and loss of the patient's home. Sputum CC occurred at a median of 33.5 (IQR 16–55, n = 46) days. Treatment success was high (74%, 74/100) and mortality low (1%, 1/100). A significant proportion of the cohort had “neutral” results due to deportation and transfer overseas (12%, (12/100)). 14% (14/100) had negative outcomes for which poor adherence was the main reason (62%, 9/14).
Conclusions |
Successful outcome is common in recognised centres and limited by adherence rather than microbiological failure. Duration of hospital admission is influenced by lack of suitable housing and some variation in public health practice. Wider access to long-term assisted living facilities could improve completion rates.
Le texte complet de cet article est disponible en PDF.Highlights |
• | Treatment practices and outcomes for MDR-TB treatment in the UK are described. |
• | Treatment success is high limited by adherence rather than microbiological failure. |
• | Variations in public health practice and housing lead to long hospital admissions. |
• | New models and infrastructure are required to reduce poor adherence. |
• | New methods using whole genome sequencing are required to shorten hospitalisation. |
Keywords : Tuberculosis
Plan
Vol 74 - N° 3
P. 260-271 - mars 2017 Retour au numéro
Article précédent
- Determining vancomycin Etest MICs in patients with MRSA bloodstream infection does not support switching antimicrobials
- Nina J. Hos, Nathalie Jazmati, Danuta Stefanik, Martin Hellmich, Halil AlSael, Winfried V. Kern, Siegbert Rieg, Hilmar Wisplinghoff, Harald Seifert, Achim J. Kaasch
- Evaluation of vitamin status in patients with pulmonary tuberculosis
- Jongwon Oh, Rihwa Choi, Hyung-Doo Park, Hyun Lee, Byeong-Ho Jeong, Hye Yun Park, Kyeongman Jeon, O Jung Kwon, Won-Jung Koh, Soo-Youn Lee
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?